首页> 外文期刊>Pain. >Stimulus-dependent specificity for annexin 1 inhibition of the inflammatory nociceptive response: the involvement of the receptor for formylated peptides.
【24h】

Stimulus-dependent specificity for annexin 1 inhibition of the inflammatory nociceptive response: the involvement of the receptor for formylated peptides.

机译:膜联蛋白1抑制炎症伤害反应的刺激依赖性特异性:甲酰化肽受体的参与。

获取原文
获取原文并翻译 | 示例
           

摘要

In this study we investigated how the peptides derived from the glucocorticoid-inducible protein annexin 1 are able to alter the nociceptive threshold of mice. The effects of the annexin1 fragment 2-26 (Anxa1(2-26)) on nociceptive threshold were studied using both chemical (formalin test) and thermal (hot plate and tail flick test) nociceptive stimuli on mice. Subcutaneous administration of Anxa1(2-26) into the dorsal surface of the mouse's hind paw was able to selectively reduce formalin-induced nociceptive behavior in the last phase of the test. The same effect was observed after intracerebroventricular administration, however, this was not the case when performing the hot plate or tail flick tests. Of the shortest Anxa1(2-26)-derived peptides, Anxa1(2-12) reduced the nociceptive response to formalin, however, the Anxa1(2-6) did not. The possible involvement of the receptors for formylated peptide in the anti-nociceptive action of Anxa1(-26) and Anxa1(2-12) was studied, choosing the formalin test. Wefound that the formyl peptide receptor agonist formyl-MLF (fMLF) induced anti-nociceptive effects in the formalin test both after the peripheral and central administration. The formyl peptide receptor antagonist N-t-butoxycarbonyl-MLP did not alter the response to formalin, but it was able to block the anti-nociceptive effects of Anxa1(2-26,) Anxa1(2-12) and fMLF after peripheral or central administration. These results indicate that exogenously administered Anxa1 can peripherally and centrally inhibit the nociceptive transmission associated with inflammatory processes through a mechanism that involves formyl peptide receptors.
机译:在这项研究中,我们调查了糖皮质激素诱导蛋白Annexin 1衍生的肽如何能够改变小鼠的伤害阈值。使用化学(福尔马林测试)和热(热板和甩尾试验)小鼠伤害性刺激,研究了膜联蛋白1片段2-26(Anxa1(2-26))对伤害性阈值的影响。在测试的最后阶段,将Anxa1(2-26)皮下注射到小鼠后爪的背面可选择性降低福尔马林诱导的伤害行为。脑室内给药后观察到相同的效果,但是,当进行热板或甩尾测试时情况并非如此。在最短的Anxa1(2-26)衍生肽中,Anxa1(2-12)减少了对福尔马林的伤害反应,但是Anxa1(2-6)没有。选择福尔马林试验,研究了甲酰化肽受体可能参与了Anxa1(-26)和Anxa1(2-12)的抗伤害感受作用。我们发现,甲酰肽受体激动剂甲酰基-MLF(fMLF)在福尔马林试验中在外周和中枢给药后均具有抗伤害感受作用。甲酰肽受体拮抗剂Nt-丁氧基羰基-MLP不会改变对福尔马林的反应,但能够阻断Anxa1(2-26,)Anxa1(2-12)和fMLF在外周或中枢给药后的抗伤害感受作用。这些结果表明,外源性给药的Anxa1可以通过涉及甲酰肽受体的机制,从外周和中枢抑制与炎症过程相关的伤害感受传递。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号